Systematic Assessment of Vascular Risk

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00378040
Recruitment Status : Completed
First Posted : September 19, 2006
Last Update Posted : May 16, 2016
Information provided by (Responsible Party):
Thomas Lindsay, University Health Network, Toronto

Brief Summary:

It is hypothesized that patients with vascular disease are undertreated for modifiable risk factors, leading to increased morbidity and mortality in this population.

The objective of this study is to develop a comprehensive database that will demonstrate the current adequacy of risk factor management in this high risk population, and that will provide needed guidance for future treatment options.

Condition or disease
Peripheral Vascular Disease

Study Type : Observational
Actual Enrollment : 800 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Toronto Vascular Disease Risk Factor Assessment Program: Systematic Assessment of Vascular Risk
Study Start Date : June 2004
Actual Primary Completion Date : December 2006
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   30 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Those with confirmend PAD

Inclusion Criteria:

All patients who attend the Vascular Surgery Clinic at Toronto General Hospital, St. Michael's Hospital, and St. Joseph's Health Centre who have PAD, cerebrovascular disease (CBVD), or aneurysms will be eligible for this study. Patients who are currently enrolled in other clinical studies are eligible for this study; however proper adherence to the other study will take precedence over of the current proposal.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00378040

Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4
Sponsors and Collaborators
University Health Network, Toronto
Principal Investigator: Thomas Lindsay, M.D Toronto General Hospital, University Health Network

Responsible Party: Thomas Lindsay, Professor of Surgery, University Health Network, Toronto Identifier: NCT00378040     History of Changes
Other Study ID Numbers: 01-541S
First Posted: September 19, 2006    Key Record Dates
Last Update Posted: May 16, 2016
Last Verified: May 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: See JAMA Surgery 2016 epublished First Author Dr M Hussain

Additional relevant MeSH terms:
Vascular Diseases
Peripheral Vascular Diseases
Peripheral Arterial Disease
Cardiovascular Diseases
Arterial Occlusive Diseases